135 related articles for article (PubMed ID: 11441811)
1. FDA committee gives new antibiotic mixed endorsement.
Clin Infect Dis; 2001 Jun; 32(12):i. PubMed ID: 11441811
[No Abstract] [Full Text] [Related]
2. Limit Ketek to pneumonia, experts advise: advisers urge black-box warning.
Young D
Am J Health Syst Pharm; 2007 Jan; 64(2):124-5. PubMed ID: 17215452
[No Abstract] [Full Text] [Related]
3. [Telithromycin in daily practice in admission services and treatment of emergencies].
Potel G
Presse Med; 2003 May; 32(19):904-5. PubMed ID: 12870401
[No Abstract] [Full Text] [Related]
4. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia.
Wu JH; Howard DH; McGowan JE; Frau LM; Dai WS
Clin Ther; 2004 Dec; 26(12):2153-62. PubMed ID: 15823779
[TBL] [Abstract][Full Text] [Related]
5. [Importance in respiratory tract infections. Ketolides: clinical aspects].
Lorenz J; Steiert P
Pharm Unserer Zeit; 2004; 33(1):42-6. PubMed ID: 14968712
[No Abstract] [Full Text] [Related]
6. Activity of telithromycin against key pathogens associated with community-acquired respiratory tract infections.
Low DE; Felmingham D; Brown SD; Rangaraju M; Nusrat R
J Infect; 2004 Aug; 49(2):115-25. PubMed ID: 15236918
[TBL] [Abstract][Full Text] [Related]
7. FDA and the safe and appropriate antibiotic use of fluoroquinolones.
Tillotson GS
Lancet Infect Dis; 2016 Mar; 16(3):e11-2. PubMed ID: 26973315
[No Abstract] [Full Text] [Related]
8. Telithromycin: the perils of hasty adoption and persistence of off-label prescribing.
Gleason PP; Walters C; Heaton AH; Schafer JA
J Manag Care Pharm; 2007 Jun; 13(5):420-5. PubMed ID: 17605513
[TBL] [Abstract][Full Text] [Related]
9. [Telithromycin, first ketolide to diversify the management of community-acquired respiratory tract infections. Importance in emergency care].
Solignac M
Presse Med; 2002 Dec; 31(40):1909-14. PubMed ID: 12579086
[No Abstract] [Full Text] [Related]
10. Telithromycin in lower respiratory tract infections.
Blasi F; Cazzola M; Tarsia P; Aliberti S; Baldessari C; Valenti V
Future Microbiol; 2006 Jun; 1(1):7-16. PubMed ID: 17661681
[TBL] [Abstract][Full Text] [Related]
11. New antibiotic approved for community-acquired infections.
Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470200
[No Abstract] [Full Text] [Related]
12. Telithromycin and the FDA: implications for the future.
Shlaes DM; Moellering RC
Lancet Infect Dis; 2008 Feb; 8(2):83-5. PubMed ID: 18222155
[No Abstract] [Full Text] [Related]
13. [Spiramycin and roxytromycin for the treatment of pneumonia and chronic bronchitis exacerbation].
Nonikov VE; Il'kovich MM; Konstantinova TD; Korovina OV; Lenkova NI; Ovcharenko SI; Peshkova OA; Simanenkov VI; Sinopal'nikov AI; Fedorova TA; Iakovlev SV
Antibiot Khimioter; 2001; 46(3):26-8. PubMed ID: 11548278
[No Abstract] [Full Text] [Related]
14. Macrolides in community-acquired pneumonia: does the bell toll for thee?
Granowitz EV; Brown RB
Chest; 2005 Sep; 128(3):1089-93. PubMed ID: 16162689
[No Abstract] [Full Text] [Related]
15. [A new antibiotic: levofloxacine].
Douadi Y; Lescure X; Schmit JL
Presse Med; 2000 Jun; 29(21):1184-5. PubMed ID: 10906942
[No Abstract] [Full Text] [Related]
16. [Telithromycin: a new therapeutic option for community-acquired respiratory infection].
Muñoz MJ; Azanza JR; Escolar M; Macaya A; Gil FJ
Rev Med Univ Navarra; 2002; 46(3):37-44. PubMed ID: 12685116
[No Abstract] [Full Text] [Related]
17. Clinical efficacy of new antibacterial therapies in at-risk populations.
Lorenz J
J Infect; 2002 Feb; 44 Suppl A():25-30. PubMed ID: 12150492
[TBL] [Abstract][Full Text] [Related]
18. Clinical management of respiratory tract infections in the community: experience with telithromycin.
Quintiliani R
Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
[TBL] [Abstract][Full Text] [Related]
19. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods.
Gonzales R; Bartlett JG; Besser RE; Cooper RJ; Hickner JM; Hoffman JR; Sande MA
Ann Emerg Med; 2001 Jun; 37(6):690-7. PubMed ID: 11385342
[TBL] [Abstract][Full Text] [Related]
20. [Etiology of community-acquired bronchitis and pneumonia in young children and the choice of antibacterial therapy].
Samsygina GA; Okhlopkova KA; Suslova OV
Antibiot Khimioter; 2000; 45(11):29-30. PubMed ID: 11210300
[No Abstract] [Full Text] [Related]
[Next] [New Search]
